Stanley Chamberlain Email

Chief Scientific Officer . T3D Therapeutics

Current Roles

Employees:
17
Revenue:
$3.4M
About
T3D Therapeutics' mission is to develop its lead drug product candidate, T3D-959, as a potential ‘First-in-Class' and ‘Best-in-Class' disease-modifying, breakthrough medicine for the treatment of Alzheimer's disease with the potential to slow, stop or reverse the course of the disease. The Company is also seeking to maximize the therapeutic utility of T3D-959 and has initiated pre-clinical studies in Huntington's Disease models.
T3D Therapeutics Address
68 T W Alexander Drive
Durham, NC
United States
T3D Therapeutics Email

Past Companies

T3D Therapuetics, IncChief Scientific Officer
T3D Therapeutics, IncVp of Chemistry and drug development
PurThread TechnologiesChief Scientific Officer

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.